Author

Brandon R. Driver

Observed name: Brandon Driver

Institutions: University of North Carolina at Chapel Hill, Houston Methodist, Weill Cornell Medicine, UNC Lineberger Comprehensive Cancer Center

Observed institutions: University of North Carolina at Chapel Hill, Houston Methodist, Shriners Hospitals for Children - Galveston, Weill Cornell Medicine, UNC Lineberger Comprehensive Cancer Center, The University of Texas Medical Branch at Galveston

OpenAlex ID: A5063400399

The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection

2011 · Christopher D. Romero, Tushar K. Varma, et al. · Infection and Immunity · 113

Quality Control Practices for Chemistry and Immunochemistry in a Cohort of 21 Large Academic Medical Centers

2018 · Matthew W Rosenbaum, James G Flood, et al. · American Journal of Clinical Pathology · 71

Regulation of Lymphocyte Trafficking by CXC Chemokine Receptor 3 during Septic Shock

2011 · Daniela S. Herzig, Brandon R. Driver, et al. · American Journal of Respiratory and Critical Care Medicine · 48

Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas

2017 · Brandon R. Driver, Ross A. Miller, et al. · Archives of Pathology & Laboratory Medicine · 33

Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria

2015 · Brandon R. Driver, Bryce P. Portier, et al. · Archives of Pathology & Laboratory Medicine · 28

Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma

2015 · Brandon R. Driver, Roberto Barrios, et al. · Archives of Pathology & Laboratory Medicine · 21

Interpathologist Diagnostic Agreement for Non–Small Cell Lung Carcinomas Using Current and Recent Classifications

2018 · William K. Funkhouser, D. Neil Hayes, et al. · Archives of Pathology & Laboratory Medicine · 12

Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non–Small Cell Lung Carcinoma

2018 · Paloma del C. Monroig-Bosque, Brandon Driver, et al. · Archives of Pathology & Laboratory Medicine · 6

P3.02c-064 Higher PD-L1 Expression Correlates with Solid and High Grade Lung Adenocarcinomas: Implications for Immunotherapy Selection

2017 · Brandon Driver, Ross Miller, et al. · Journal of Thoracic Oncology

Works count: 9

Citation count: 332

H-index: 7

I10-index: 7